Illustrates the movement in Barclays' CET1 ratio from Q424 to Q125, highlighting positive and negative contributors such as attributable profit, share buybacks, and RWA changes, ending at 13.9%.

Shows Barclays’ CET1 ratio (13.6%) exceeds the regulatory minimum (12.0%-12.2%) providing significant buffer. Explains expected future reduction in capital requirements and ongoing flexibility in managing regulatory capital targets.

Focuses on the bank's CET1 ratio movements within a target range, detailing specific impacts from dividends and other adjustments on capital.

Shows the progression of CET1 capital across different periods, highlighting the contributions and deductions leading to the final 3Q22 figure.

Shows Barclays’ CET1 and leverage ratios versus regulatory minimums as of H1 2024. Emphasizes that the bank holds capital well above the thresholds, ensuring a strong capital base and regulatory compliance.

Compares Q1 2024 capital metrics with Q4 2023, highlighting decreases in CET1 and leverage ratios due to capital changes and FX effects. The slide shows MREL/TLAC composition and surplus over regulatory requirements.

Provides a detailed overview of Deutsche Bank’s capital metrics as of Q1 2025. It includes movements in CET1 and leverage ratios and shows sufficient MREL/TLAC buffers above regulatory requirements.

Summarizes capital adequacy and regulatory ratios as of Q2 2024. The CET1 and leverage ratios improved, driven by capital changes. MREL/TLAC status shows a surplus above requirements, reinforcing financial strength amid regulatory requirements.

This slide compares Barclays' actual CET1 and UK leverage ratios against regulatory minimums. It demonstrates that the bank maintains sufficient capital and leverage buffers above the required thresholds, remaining in its 13–14% CET1 target range.

Outlines changes in capital ratios (CET1, leverage) and capital buffer compliance (MREL/TLAC). Discusses effects from earnings, FX, regulation, and litigation settlements. Emphasizes strength in regulatory buffers and stable leverage.

Shows that Barclays exceeds FY24 minimum CET1 (10.6%) and UK leverage (3.45%) requirements with actual ratios of 12.1% and 5.8% respectively. Charts break down the components of regulatory minimums and the capital buffers in place.

Presents historical trends (2019–Q125) for CET1 ratio, loan-to-deposit ratio, liquidity coverage ratio, and net stable funding ratio, emphasizing prudence and consistency across regulatory and capital metrics.

This slide displays the CET1 ratio movements over a period with a focus on financial metrics and future considerations for maintaining the capital ratio. It highlights key impacts and planned financial adjustments.

Highlights CET1 ratio movements and the significant headroom to the MDA, including regulatory updates and key financial data.

Explains the strong CET1 ratio and the significant headroom to the MDA, including key regulatory and financial metrics.

The slide presents the target CET1 ratio of greater than 13.5% by 2025, outlining the steps and capital actions required to achieve this financial stability goal.

This slide outlines the stability of the CET1 ratio at 13.8% despite market fluctuations. It shows the impact of CRR3, FX effects, and capital changes. Risk-weighted assets slightly decreased to €352bn. The highlights explain how capital efficiency measures and operational risk RWA changes contributed to the overall CET1 stability and provide context for the underlying asset and risk trends.

The slide indicates Deutsche Bank’s CET1 ratio stability at 13.8%, detailing drivers of change such as FX effects, RWA changes, and capital movements. The slide also projects the impact of CRR3 regulation expected in Q1 2025.

A historical bar chart tracks CET1 ratio shifts during past EBA stress tests, comparing capital depletion (bps) and capital flexibility. 2023 results show slightly less depletion than 2021, with better capital buffers. Emphasizes the importance of resilience under severe scenarios.

The slide provides a detailed breakdown of the CET1 ratio requirements and actual performance, emphasizing regulatory minimums and the current status within the target range for capital adequacy.

This slide presents the results of a CFO survey covering nine CEE countries with 312 responses, conducted between May and August 2022.

Discusses the shifting priorities of CFOs during the COVID-19 pandemic, emphasizing the focus on cashflow management as the highest priority, followed by forecasting and people management. This indicates a strategic pivot towards essential financial management and resilience building in uncertain times.

Discusses the resources necessary for CFOs to achieve their business priorities, including investment in IT infrastructure, stakeholder alignment, and team skills. The pie chart visually represents the distribution of these resources, highlighting the critical areas for successful financial management.

Analyzes the primary business priorities for CFOs and stakeholders, focusing on performance, transformation, risk management, and transactions. The charts provide a visual comparison of these priorities and their relative importance, revealing areas of alignment and divergence.

Details the allocation of CFOs' time across various functions, emphasizing differences between formal and informal practices. Highlights the importance of flexibility and adaptability in CFO roles, supported by a quote from a private equity investor discussing the need for versatile financial leadership.

Analyzes the inverse relationship between rising COVID-19 cases and falling case fatality rates globally, with three main causes: better identification, different age mix, and improved treatment.

Shows that despite a spike in COVID-19 cases in the U.S., the case fatality rate (CFR) and deaths have not risen proportionately. Explains this trend with factors such as increased testing, changes in age mix of cases, and better treatment protocols.

Shows that the global daily COVID-19 CFR has declined and converged around 2% across regions. Introduces the distinction between CFR and IFR and discusses why CFR may vary.

This slide explains the funding allocation under the US CHIPS Act, emphasizing that only 5% is directed to legacy chip production. It breaks down how over $52B will be spent, highlighting delays in impact and lack of support for industrial/automotive applications.

This slide presents a breakdown of CHIPS Act spending from 2022–2026. It categorizes appropriations for R&D, loan programs, tax credits, and specific funds for semiconductor development and innovation. It communicates strategic investment priorities for boosting U.S. technology leadership.